等待開盤 08-19 09:30:00 美东时间
0.000
0.00%
Taysha Gene Therapies plans to report its second-quarter 2025 financial results and host a corporate update call and webcast on August 12 at 8:30 AM ET. The company focuses on developing AAV-based gene therapies for severe CNS disorders, with its lead program TSHA-102 targeting Rett syndrome, a rare neurodevelopmental disease lacking effective treatments. Taysha aims to address unmet medical needs by leveraging its expertise and clinically proven...
08-05 20:05
An update from Tungsten Mining NL ( ($AU:TGN) ) is now available. Tungsten Mini...
07-24 06:27